Giacomo Caldarola (G Caldarola)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 36

Top Topics

Ejection Fraction

Chronic Kidney Disease

Atopic Dermatitis

Top Venues

Expert opinion on biological therapy

Journal of the European Academy of Dermatology and Venereology : JEADV

International journal of dermatology

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

This page only lists publications with an associated author ORCID identifier.

Publications

Sara Cacciapuoti, Luca Potestio, Gallo Lucia, Musumeci Maria Letizia, Giacomo Caldarola, Domenico D'Amico, Caudullo Francesco, Papaianni Valeria, Clara De Simone, Ketty Peris, Matteo Megna
Short-term efficacy of tildrakizumab on difficult-to-treat areas: a real-world experience. International journal of dermatology (2024)
Laura Calabrese, Gennaro Marco Falco, Giacomo Caldarola, Alessandro Di Stefani, Magda D'Agostino, Ketty Peris, Clara De Simone
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 22 (3) (2024)
Orsini Diego, Giacomo Caldarola, Annunziata Dattola, Elena Campione, Nicoletta Bernardini, Pasquale Frascione, Clara De Simone, Antonio Giovanni Richetta, Marco Galluzzo, Nevena Skroza, Chiara Assorgi, Emanuele Amore, Gennaro Marco Falco, Ruslana Gaeta Shumak, Fabio Artosi, Giulia Maretti, Concetta Potenza, Luca Bianchi, Giovanni Pellacani, Ketty Peris, Claudio Bonifati, Dario Graceffa
Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER - study). The Journal of dermatological treatment 35 (1) (2024)
Laura Calabrese, Gennaro Marco Falco, Giacomo Caldarola, Alessandro Di Stefani, Magda D'Agostino, Ketty Peris, Clara De Simone
Paradoxical skin reaction to certolizumab, an overlap of neutrophilic dermatoses. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG (2024)
Laura Calabrese, Gennaro Marco Falco, Giacomo Caldarola, Alessandro Di Stefani, Magda D'Agostino, Ketty Peris, Clara De Simone
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 22 (3) (2024)
Laura Calabrese, Gennaro Marco Falco, Giacomo Caldarola, Alessandro Di Stefani, Magda D'Agostino, Ketty Peris, Clara De Simone
Paradoxical skin reaction to certolizumab, an overlap of neutrophilic dermatoses. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 22 (3) (2024)
Laura Calabrese, Gennaro Marco Falco, Giacomo Caldarola, Alessandro Di Stefani, Magda D'Agostino, Ketty Peris, Clara De Simone
Paradoxical skin reaction to certolizumab, an overlap of neutrophilic dermatoses. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 22 (3) (2024)
Marco Galluzzo, Emanuele Trovato, Marina Talamonti, Giacomo Caldarola, Lucia Di Nardo, Laura Lazzeri, Cristina Mugheddu, Martina Burlando, Riccardo Balestri, Nicoletta Bernardini, Gabriele Biondi, Laura Vellucci, Filomena Russo, Clara De Simone, Claudia Paganini, Giulia Rech, Emanuele Claudio Cozzani, Laura Atzori, Maria Antonia Montesu, Concetta Potenza, Andrea Chiricozzi, Pietro Rubegni
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study. Journal of clinical medicine 13 (13) (2024)
Giacomo Caldarola, Daniele O Traini, Gennaro Marco Falco, Andrea Chiricozzi, Eleonora De Luca, Maria Mannino, Luca Pellegrino, Ketty Peris, Clara De Simone
Clinical, epidemiological, and therapeutic hallmarks of pyoderma gangrenosum: a case series of 35 patients. International journal of dermatology (2024)
Bianca Maria Piraccini, Francesca Pampaloni, Stephano Cedirian, F Quadrelli, Francesca Bruni, Luca Rapparini, Gemma Caro, M C Acri, L Ala, Alfredo Rossi, G Pellacani, Francesco Lacarrubba, G Micali, F Dall'Oglio, Marina Vastarella, M Cantelli, P Nappa, Laura Diluvio, L Bianchi, Laura Gnesotto, Andrea Sechi, L Naldi, F Tassone, K Peris, Giacomo Caldarola, L M Pinto, Giampiero Girolomoni, F Marangoni, Francesco Bellinato, Paolo Gisondi, I Scandagli, Francesca Prignano, N Pimpinelli, C Tomasini, Stefania Barruscotti, Edoardo De Simoni, O Simonetti, F Ambrogio, C Foti, V Boccaletti, A Fraghì, Angelo Valerio Marzano, M A Mattioli, L Rocca, M Barbareschi, S M Ferrucci, Giuseppe Gallo, Simone Ribero, Pietro Quaglino, R Balestri, T Ioris, R D Caposiena Caro, I Zalaudek, E Vagnozzi, Maria-Concetta Fargnoli, C Caponio, P Rubegni, Elisa Cinotti, Emanuele Trovato, M Romanelli, Valentina Dini, Flavia Manzo Margiotta, Claudio Feliciani, M B de Felici Del Giudice, Laura Atzori, S Sanna, S Lembo, Annunziata Raimondo, Michela Magnano, Michela Valeria Rita Starace
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Giacomo Caldarola, Daniele O Traini, Gennaro Marco Falco, Andrea Chiricozzi, Eleonora De Luca, Maria Mannino, Luca Pellegrino, Ketty Peris, Clara De Simone
Clinical, epidemiological, and therapeutic hallmarks of pyoderma gangrenosum: a case series of 35 patients. International journal of dermatology 63 (9) (2024)
Orsini Diego, Giacomo Caldarola, Annunziata Dattola, Elena Campione, Nicoletta Bernardini, Pasquale Frascione, Clara De Simone, Antonio Giovanni Richetta, Marco Galluzzo, Nevena Skroza, Chiara Assorgi, Emanuele Amore, Gennaro Marco Falco, Ruslana Gaeta Shumak, Fabio Artosi, Giulia Maretti, Concetta Potenza, Luca Bianchi, Giovanni Pellacani, Ketty Peris, Claudio Bonifati, Dario Graceffa
Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER - study). The Journal of dermatological treatment 35 (1) (2024)
Marco Galluzzo, Emanuele Trovato, Marina Talamonti, Giacomo Caldarola, Lucia Di Nardo, Laura Lazzeri, Cristina Mugheddu, Martina Burlando, Riccardo Balestri, Nicoletta Bernardini, Gabriele Biondi, Laura Vellucci, Filomena Russo, Clara De Simone, Claudia Paganini, Giulia Rech, Emanuele Claudio Cozzani, Laura Atzori, Maria Antonia Montesu, Concetta Potenza, Andrea Chiricozzi, Pietro Rubegni
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study. Journal of clinical medicine 13 (13) (2024)
Sara Cacciapuoti, Luca Potestio, Lucia Gallo, Maria Letizia Musumeci, Giacomo Caldarola, Domenico D'Amico, Francesco Caudullo, Valeria Papaianni, Clara De Simone, Ketty Peris, Matteo Megna
Short-term efficacy of tildrakizumab on difficult-to-treat areas: a real-world experience. International journal of dermatology (2024)
Giulia Coscarella, Dalma Malvaso, Maria Mannino, Giacomo Caldarola, Barbara Fossati, Clara De Simone, Andrea Chiricozzi, Ketty Peris
The preclinical discovery and development of deucravacitinib for the treatment of psoriasis. Expert opinion on drug discovery (2023)
Giacomo Caldarola, Andrea Chiricozzi, Matteo Megna, P Dapavo, A Giunta, M Burlando, P Malagoli, V Dini, Marco Mariani, Gabriella Fabbrocini, P Quaglino, Luca Bianchi, A Parodi, Ketty Peris, C De Simone
Real-life experience with ixekizumab in plaque psoriasis: a multi-center, retrospective, 3-year study. Expert opinion on biological therapy (2023)
Andrea Chiricozzi, S M Ferrucci, L Di Nardo, N Gori, A Balato, M Ortoncelli, Martina Maurelli, Marco Galluzzo, M Munera Campos, T Seremet, Giacomo Caldarola, C De Simone, E Ippoliti, Tiago Torres, S Gkalpakiotis, C Conrad, J M Carrascosa, L Bianchi, G Argenziano, S Ribero, G Girolomoni, A V Marzano, K Peris, null null
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study. Expert opinion on biological therapy 23 (12) (2023)
Giacomo Caldarola, Andrea Chiricozzi, Matteo Megna, P Dapavo, A Giunta, M Burlando, P Malagoli, V Dini, Marco Mariani, Gabriella Fabbrocini, P Quaglino, Luca Bianchi, A Parodi, Ketty Peris, C De Simone
Real-life experience with ixekizumab in plaque psoriasis: a multi-center, retrospective, 3-year study. Expert opinion on biological therapy (2023)
Andrea Chiricozzi, S M Ferrucci, L Di Nardo, N Gori, A Balato, M Ortoncelli, Martina Maurelli, Marco Galluzzo, M Munera Campos, T Seremet, Giacomo Caldarola, C De Simone, E Ippoliti, Tiago Torres, S Gkalpakiotis, C Conrad, J M Carrascosa, L Bianchi, G Argenziano, S Ribero, G Girolomoni, A V Marzano, K Peris, null null
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study. Expert opinion on biological therapy (2023)
Andrea Chiricozzi, Giacomo Dal Bello, Niccolò Gori, Lucia Di Nardo, Donatella Schena, Giacomo Caldarola, Martina Maurelli, Clara De Simone, Giampiero Girolomoni, Ketty Peris
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study. The Journal of dermatological treatment 34 (1) (2023)
Alexandra Maria Giovanna Brunasso, Martina Burlando, Fabrizio Amoruso, Luisa Arancio, Giovanna Malara, Raffaella Manzo, Maria Antonia Montesu, Giacomo Caldarola
Risankizumab: Daily Practice Experience of High Need Patients. Biomedicines 11 (6) (2023)
Andrea Chiricozzi, S M Ferrucci, L Di Nardo, N Gori, A Balato, M Ortoncelli, Martina Maurelli, Marco Galluzzo, M Munera Campos, T Seremet, Giacomo Caldarola, C De Simone, E Ippoliti, Tiago Torres, S Gkalpakiotis, C Conrad, J M Carrascosa, L Bianchi, G Argenziano, S Ribero, G Girolomoni, A V Marzano, K Peris, null null
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study. Expert opinion on biological therapy 23 (12) (2023)
Giacomo Caldarola, Gennaro Marco Falco, Laura Calabrese, Alessandra D'Amore, Andrea Chiricozzi, Marco Mariani, Gerardo Palmisano, Clara De Simone, Ketty Peris
Drug survival of biologics and non-biologics in patients affected by palmoplantar psoriasis: a "real-world", mono-center experience. International journal of dermatology (2023)
Giacomo Caldarola, Eleonora De Luca, Marco Mariani, Andrea Chiricozzi, Ketty Peris, Clara De Simone
Drug survival of methotrexate and predictor factors for discontinuation in psoriasis. International journal of dermatology (2023)
L Quattrini, Giacomo Caldarola, Gennaro Marco Falco, L M Pinto, Ketty Peris
Successfull treatment with tralokinumab in patients with atopic dermatitis and dupilumab-induced psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Andrea Chiricozzi, S M Ferrucci, L Di Nardo, N Gori, A Balato, M Ortoncelli, Martina Maurelli, Marco Galluzzo, M Munera Campos, T Seremet, Giacomo Caldarola, C De Simone, E Ippoliti, Tiago Torres, S Gkalpakiotis, C Conrad, J M Carrascosa, L Bianchi, G Argenziano, S Ribero, G Girolomoni, A V Marzano, K Peris, null null
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study. Expert opinion on biological therapy 23 (12) (2023)
Alexandra Maria Giovanna Brunasso, Martina Burlando, Fabrizio Amoruso, Luisa Arancio, Giovanna Malara, Raffaella Manzo, Maria Antonia Montesu, Giacomo Caldarola
Risankizumab: Daily Practice Experience of High Need Patients. Biomedicines 11 (6) (2023)
Francesco Bellinato, Paolo Gisondi, Anna Balato, Giacomo Caldarola, Edoardo Cammarata, Elena Campione, Andrea Carugno, Andrea Conti, Monica Corazza, Paolo Dapavo, Annunziata Dattola, Vito Di Lernia, Massimo Gasperini, Salvatore Panduri, Francesca Prignano, Francesca Satolli, Enzo Spisni, Giampiero Girolomoni
Awareness of obesity among patients with psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Giacomo Caldarola, Marco Galluzzo, Nicoletta Bernardini, Laura Calabrese, Marta Grimaldi, Gaia Moretta, Gianluca Pagnanelli, Ruslana Gaeta Shumak, Marina Talamonti, Lorenzo Tofani, Sabatino Pallotta, Ketty Peris, Concetta Potenza, Clara De Simone, Elena Campione
Tildrakizumab in moderate-to-severe plaque psoriasis: A multicenter, retrospective, real-life study. Dermatologic therapy 35 (6) (2022)
Giacomo Caldarola, Arianna Zangrilli, Nicoletta Bernardini, Mauro Bavetta, Clara De Simone, Dario Graceffa, Claudio Bonifati, Sara Faleri, Domenico Giordano, Marco Mariani, Adriana Micheli, Gaia Moretta, Gianluca Pagnanelli, Vincenzo Panasiti, Alessia Provini, Antonio Richetta, Ketty Peris, Luca Bianchi
Risankizumab for the treatment of moderate-to-severe psoriasis: A multicenter, retrospective, 1 year real-life study. Dermatologic therapy 35 (6) (2022)
Gianluca Avallone, Francesco Cavallo, C Astrua, Giacomo Caldarola, Conforti Claudio, C De Simone, N di Meo, A di Stefani, Giovanni Genovese, Carlo Alberto Maronese, Angelo Valerio Marzano, R Parente, Pietro Quaglino, G Roccuzzo, F Tassone, I Zalaudek, R Senetta, Simone Ribero
Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experience. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (11) (2022)
Andrea Chiricozzi, Niccolò Gori, Martina Maurelli, Paolo Gisondi, Giacomo Caldarola, Clara De Simone, Ketty Peris, Giampiero Girolomoni
Biological agents targeting interleukin-13 for atopic dermatitis. Expert opinion on biological therapy 22 (5) (2022)
L Quattrini, L Verardi, Giacomo Caldarola, G Peluso, C De Simone, M D'Agostino
New onset of remitting seronegative symmetrical synovitis with pitting oedema and palmoplantar psoriasis flare-up after Sars-Cov-2 vaccination. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (11) (2021)
Marco Galluzzo, Giacomo Caldarola, C De Simone, N Bernardini, Gaia Moretta, Sabatino Pallotta, E Botti, Elena Campione, Federico Pirro, C Potenza, Luca Bianchi, Ketty Peris
Use of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy. Expert opinion on biological therapy 21 (9) (2021)
Arianna Zangrilli, Giacomo Caldarola, Nicoletta Bernardini, Mauro Bavetta, Dario Graceffa, Claudio Bonifati, Franca Cantoresi, Sara Faleri, Domenico Giordano, Marco Mariani, Adriana Micheli, Gaia Moretta, Federico Pirro, Gianluca Pagnanelli, Vincenzo Panasiti, Alessia Provini, Antonio Giovanni Richetta, Lidia Sacchelli, Luca Bianchi, Ketty Peris
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy. Expert opinion on biological therapy 21 (9) (2021)
Annunziata Dattola, Anna Balato, Matteo Megna, Paolo Gisondi, Giampiero Girolomoni, C De Simone, Giacomo Caldarola, E Cama, S Piaserico, Maria-Concetta Fargnoli, R Fidanza, A Parodi, Martina Burlando, A Offidani, F Diotallevi, C Potenza, A Conti, A Chiricozzi, E Campione, L Bianchi
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (12) (2020)